RESEARCH PAPER
Knowledge, attitudes, and practices towards COVID-19 and COVID-19 vaccines among Obstetrician-Gynaecologists
1
University of Parma, Parma, Italy
2
Azrieli Faculty of Medicine, Bar-Ilan University, Tel Aviv, Israel
3
Baylor College of Medicine, Houston, United States
4
LUXMED Group, Poland
5
International European University, Kyiv, Ukraine
6
Institute of Rural Health, Lublin, Poland
7
Medical University of Warsaw, Warsaw, Poland
Ann Agric Environ Med. 2023;30(4):669-676
KEYWORDS
TOPICS
Biological agents posing occupational risk in agriculture, forestry, food industry and wood industry and diseases caused by these agents (zoonoses, allergic and immunotoxic diseases)Health effects of chemical pollutants in agricultural areas , including occupational and non-occupational effects of agricultural chemicals (pesticides, fertilizers) and effects of industrial disposal (heavy metals, sulphur, etc.) contaminating the atmosphere, soil and waterExposure to physical hazards associated with the use of machinery in agriculture and forestry: noise, vibration, dustPrevention of occupational diseases in agriculture, forestry, food industry and wood industryState of the health of rural communities depending on various factors: social factors, accessibility of medical care, etc.
ABSTRACT
Introduction and objective:
The article assesses the knowledge, attitudes, and practices of Obstetrician-Gynaecologists (OB/GYNs) in Israel regarding COVID-19, its impact on fertility, pregnancy and childbirth, and their positions on COVID-19 vaccines.
Material and methods:
A cross-sectional anonymous survey was employed, and the data analyzed using logistic regression models.
Results:
A total of 172 OB/GYN participants aged 44.9 years, primarily female (59.7%), mostly attending physicians (60.4%), had a mean knowledge score of 75.62%, with 81.1% having sufficient knowledge about general COVID-19 information, 11.9% having specific knowledge about pregnancy, birth, and breastfeeding, and 40.3% having knowledge about COVID-19 vaccination. Notably, only 27% of participants correctly identified the increased risk of preeclampsia in pregnant women with COVID-19. Nevertheless, all OB/GYN participants recommended the COVID-19 vaccination during pregnancy. The majority (65.1%) recommended vaccination across all trimesters, while a smaller percentage recommended it only in the second (25%) or third (6%) trimesters, and very few in the first trimester (4%). The study found that attitudes towards vaccination were influenced by workplace, role, religion, religious observance, and marital status.
Conclusions:
The study showed a good level of knowledge regarding COVID-19 vaccines which contributed to OB/GYNs’ recommendations to their patients. These findings can be valuable for designing future COVID-19 vaccination campaigns.
The article assesses the knowledge, attitudes, and practices of Obstetrician-Gynaecologists (OB/GYNs) in Israel regarding COVID-19, its impact on fertility, pregnancy and childbirth, and their positions on COVID-19 vaccines.
Material and methods:
A cross-sectional anonymous survey was employed, and the data analyzed using logistic regression models.
Results:
A total of 172 OB/GYN participants aged 44.9 years, primarily female (59.7%), mostly attending physicians (60.4%), had a mean knowledge score of 75.62%, with 81.1% having sufficient knowledge about general COVID-19 information, 11.9% having specific knowledge about pregnancy, birth, and breastfeeding, and 40.3% having knowledge about COVID-19 vaccination. Notably, only 27% of participants correctly identified the increased risk of preeclampsia in pregnant women with COVID-19. Nevertheless, all OB/GYN participants recommended the COVID-19 vaccination during pregnancy. The majority (65.1%) recommended vaccination across all trimesters, while a smaller percentage recommended it only in the second (25%) or third (6%) trimesters, and very few in the first trimester (4%). The study found that attitudes towards vaccination were influenced by workplace, role, religion, religious observance, and marital status.
Conclusions:
The study showed a good level of knowledge regarding COVID-19 vaccines which contributed to OB/GYNs’ recommendations to their patients. These findings can be valuable for designing future COVID-19 vaccination campaigns.
REFERENCES (59)
1.
Dutkiewicz J, Mackiewicz B, Lemieszek MK. COVID 19 – Possible interrelations with respiratory comorbidities caused by occupational exposure to various hazardous bioaerosols. Part I. Occurrence, epidemiology and presumed origin of the pandemic. Ann Agric Environ Med. 2020; 27:491–504. https://doi.org/10.26444/aaem/....
2.
Dzieciatkowski T, Szarpak L, Filipiak KJ, Jaguszewski M, Ladny JR, Smereka J. COVID-19 challenge for modern medicine. Cardiol J. 2020;27:175–183. https://doi.org/10.5603/CJ.a20....
3.
Gonczaryk A, Chmielewski J, Dziechciaz M, Wroblewska I, Luszczki JJ. Occupational exposure to biological agents in Polish paramedics: a narrative review. Disaster Emerg Med J. 2021;6:194–203. https://doi.org/10.5603/DEMJ.a....
4.
Krawczyk A, Szarpak L, Bragazzi NL, Cander B, Feduniw S, Pruc M, et al. Effect of SARS-CoV-2 infection on out-of-hospital cardiac arrest outcomes – systematic review and meta-analysis. Ann Agric Environ Med. 2023;30:369–375. https://doi.org/10.26444/aaem/....
5.
Smereka J, Szarpak L, Filipiak KJ. Modern medicine in COVID-19 era. Disaster Emerg Med J. 2020;5:103–105. https://doi.org/10.5603/DEMJ.a....
6.
World Health Organization. Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. http://www.who.int/dg/speeches....
7.
Ruetzler K, Szarpak L, Filipiak KJ, Ladny JR, Smereka J. The COVID-19 pandemic — a view of the current state of the problem. Disaster Emerg Med. 2020;5:106–107. https://doi.org/10.5603/DEMJ.a....
8.
Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020; 370:m3320. https://doi.org/10.1136/bmj.m3....
9.
Kasehagen L, Byers P, Taylor K, Kittle T, Roberts C, Collier C, et al. COVID-19–Associated Deaths After SARS-CoV-2 Infection During Pregnancy—Mississippi, March 1, 2020–October 6, 2021. Morbidity and Mortality Weekly Report 2021;70:1646.
10.
Rasmussen SA, Kelley CF, Horton JP, Jamieson DJ. Coronavirus disease 2019 (COVID-19) vaccines and pregnancy: what obstetricians need to know. Obstet Gynecol. 2021;137:408–414. https://doi.org/10.1097/AOG.00....
11.
Metz TD, Clifton RG, Hughes BL, Sandoval G, Saade GR, Grobman WA, et al; for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2021;137:571–580. https://doi.org/10.1097/AOG.00....
12.
Conde-Agudelo A, Romero R. SARS-COV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;226:68–89.e3. https://doi.org/10.1016/j.ajog....
13.
Lamptey E. Overcoming barriers to COVID-19 vaccination of pregnant women. Gynecol Obst Clin Med. 2022;2:29–33. https://doi.org/10.1016/j.gocm....
15.
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al; C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. https://doi.org/10.1056/NEJMoa....
16.
Butt AA, Omer SB, Yan P, Shaikh OS, Mayr FB. SARS-CoV-2 vaccine effectiveness in a high-risk national population in a real-world setting. Ann Intern Med. 2021;174:1404–1408. https://doi.org/10.7326/M21-15....
17.
Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al; Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021;397:99–111. https://doi.org/10.1016/S0140-....
18.
Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al; CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021;384:2273–2282. https://doi.org/10.1056/NEJMoa....
19.
Jacobs E, Van Voorhis BJ. COVID-19 Vaccination in Obstetrics and Gynecology: Addressing Concerns While Paving a Way Forward. Obstet Gynecol. 2022;139:479–480. https://doi.org/10.1097/AOG.00....
23.
Golan Y, Prahl M, Cassidy AG, Gay C, Wu AHB, Jigmeddagva U, et al. COVID-19 mRNA Vaccination in Lactation: Assessment of adverse effects and transfer of anti-SARS-CoV2 antibodies from mother to child. medRxiv. 2021:21253241. https://doi.org/10.1101/2021.0....
24.
Chen F, Zhu S, Dai Z, Hao L, Luan C, Guo Q, et al. Effects of COVID-19 and mRNA vaccines on human fertility. Hum Reprod. 2021;37:5–13. https://doi.org/10.1093/humrep....
25.
MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015; 33:4161–4164. https://doi.org/10.1016/j.vacc....
26.
Gozhenko A, Szarpak L, Jaguszewski MJ, Dey B, Popieluch J, Pruc M, et al. COVID-19 vaccine — third dose, booster dose? What is it and is it necessary? Disaster Emerg Med J. 2021;6:208–209. https://doi.org/10.5603/DEMJ.a....
27.
Jackson DN, Peterson EB, Blake KD, Coa K, Chou WYS. Americans’ trust in health information sources: Trends and sociodemographic predictors. Am J Health Promot. 2019;33:1187–1193. https://doi.org/10.1177/089011....
28.
Bogart LM, Ojikutu BO, Tyagi K, Klein DJ, Mutchler MG, Dong L, et al. COVID-19 related medical mistrust, health impacts, and potential vaccine hesitancy among Black Americans living with HIV. J Acquir Immune Defic Syndr. 2021;86:200–207. https://doi.org/10.1097/QAI.00....
29.
King I, Heidler P, Marzo RR. The Long and Winding Road: Uptake, Acceptability, and Potential Influencing Factors of COVID-19 Vaccination in Austria. Vaccines (Basel) 2021;9:790. https://doi.org/10.3390/vaccin....
30.
Herzog R, Álvarez-Pasquin MJ, Díaz C, Del Barrio JL, Estrada JM, Gil Á. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health 2013;13:154. https://doi.org/10.1186/1471-2....
31.
Zaitoon H, Sharkansky L, Ganaim L, Chistyakov I, Srugo I, Bamberger E. Evaluation of Israeli healthcare workers knowledge and attitudes toward the COVID-19 vaccine. Public Health Nurs.2022;39:415–422. https://doi.org/10.1111/phn.12....
32.
Holzmann-Littig C, Braunisch MC, Kranke P, Popp M, Seeber C, Fichtner F, et al. COVID-19 vaccination acceptance and hesitancy among healthcare workers in Germany. Vaccines (Basel) 2021;9:777. https://doi.org/10.3390/vaccin....
33.
Rapisarda V, Vella F, Ledda C, Barattucci M, Ramaci T. What prompts doctors to recommend COVID-19 vaccines: is it a question of positive emotion? Vaccines (Basel) 2021;9:578. https://doi.org/10.3390/vaccin....
34.
Albahri AH, Alnaqbi SA, Alnaqbi SA, Alshaali AO, Shahdoor SM. Knowledge, attitude, and practice regarding COVID-19 among healthcare workers in primary healthcare centers in Dubai: a cross-sectional survey, 2020. Front Public Health. 2021;9:617679. https://doi.org/10.3389/fpubh.....
35.
Youssef D, Abou Abass L, Berry A, Youssef J. Knowledge, attitudes and practices among Lebanese Obstetricians and gynecologists toward Coronavirus Disease-2019 (COVID-19) and pregnancy. ResearchSquere. 2021. https://doi.org/10.21203/rs.3.....
36.
Daskalakis G, Pergialiotis V, Antsaklis P, Theodora M, Papageorgiou D, Rodolakis A. Healthcare workers’ attitudes about vaccination of pregnant women and those wishing to become pregnant. J Perinat Med. 2022;50:363–366. https://doi.org/10.1515/jpm-20....
37.
MacQueen BD, MacQueen W. NeuroCOVID: a preliminary review. Acta Neuropsychol. 2021;19(3):389–402. doi:10.5604/01.3001.0015.2692.
38.
Aknin LB, De Neve JE, Dunn EW, Fancourt DE, Goldberg E, Helliwell JF, et al. The Neurological Consequences of Contracting COVID-19. The Lancet’s COVID-19 Commission Mental Health Task Force. Acta Neuropsychol. 2021;19(3):301–305. doi:10.5604/01.3001.0014.9953.
39.
Falahi S, Abdoli A, Kenarkoohi A. Maternal COVID-19 infection and the fetus: Immunological and neurological perspectives. New Microbes New Infect. 2023 Jun;53:101135. doi:10.1016/j.nmni.2023.101135. Epub 2023 Apr 27. PMID: 37143853; PMCID: PMC10133021.
40.
Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, Harrison PJ. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9:815–27.
41.
Pąchalska M, Góral-Półrola J, Jarosz P. Neurotherapy in Parkinson’s Disease: the path forward after SARS-CoV-2 infection and contracting COVID-19, and long COVID? Acta Neuropsychol. 2022;20(3):275–290. doi:10.5604/01.3001.0015.9804.
42.
Matschke J, Lütgehetmann M, Hagel C, Sperhake JP, Schröder AS, Edler C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919–929.
43.
Pąchalska M, Nowaczyk N. Event-related potentials studies of PTSD after infection od SARS-CoV-2 and NeuroCOVID-19. Acta Neuropsychol. 2021;19(3):347–360. doi:10.5604/01.3001.0015.2463.
44.
Łuckoś M, Cielebąk K, Kamiński P. EEG Neurofeedback in the treatment of cognitive dysfunctions after the infection of SARS-CoV-2 and long COVID-19. Acta Neuropsychol. 2021;19(3):361–372. doi:10.5604/01.3001.0015.2464.
45.
Kurd M, Hashavya S, Benenson S, Gilboa T. Seizures as the main presenting manifestation of acute SARS-CoV-2 infection in children. Seizure. 2021 Nov;92:89–93. doi:10.1016/j.seizure.2021.08.017. Epub 2021 Aug 28. PMID: 34481322.
46.
Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020;16(11):636–644.
47.
Garg RK, Paliwal VK, Gupta A. Encephalopathy in patients with COVID-19: a review. J Med Virol. 2021;93(1):206–222.
48.
Frontera JA, Melmed K, Fang T, Granger A, Lin J, Yaghi S, et al. Toxic metabolic encephalopathy in hospitalized patients with COVID-19. Neurocritical Care. 2021;35(3):693–706.
49.
Koralnik IJ, Tyler KL. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88(1):1–11.
50.
Abdoli A, Taghipour A, Pirestani M, Jahromi MAM, Roustazadeh A, Mir H, et al. Infections, inflammation, and risk of neuropsychiatric disorders: the neglected role of “co-infection” Heliyon. 2020;6(12).
51.
Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res. 2021;128(9):1323–1326.
52.
Ellington S, Olson CK. Safety of mRNA COVID-19 vaccines during pregnancy. Lancet Infect Dis. 2022;22(11):1514–1515.
53.
Alavian F, Alavian K. Pregnancy and COVID-19: physiology, some challenges, and solutions. Iranian J Obstet Gynecol Infertility. 2021;24(1):99–111.
54.
Jahanbakhsh SS, Taghavi Gilani M, Hashemian A, Rais Assadat B. Review of cardiopulmonary resuscitation in pregnant Women. Iranian J Obstet Gynecol Infertility. 2007;10(2):87–96.
55.
Yang H, Wang C, Poon L. Novel coronavirus infection and pregnancy. Ultrasound Obstet Gynecol. 2020;55(4):435.
56.
Zhao X, Jiang Y, Zhao Y, Xi H, Liu C, Qu F, et al. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening. Eur J Clin Microbiol Infect Dis. 2020;39(7):1209–1220.
57.
Edlow AG, Castro VM, Shook LL, Kaimal AJ, Perlis RH. Neuro-developmental outcomes at 1 Year in infants of mothers who tested positive for SARS-CoV-2 during pregnancy. JAMA Netw Open. 2022;5(6).
58.
Takamatsu A, Honda H, Kojima T, Murata K, Babcock HM. Promoting coronavirus disease 2019 (COVID-19) vaccination among healthcare personnel: A multifaceted intervention at a tertiary-care center in Japan. Infect Control Hosp Epidemiol. 2022;43:1201–1206. https://doi.org/10.1017/ice.20....
59.
Deruelle P, Couffignal C, Sibiude J, Vivanti AJ, Anselem O, Luton D, et al. Prenatal care providers’ perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women. PLoS One 2021;16:e0256080. https://doi.org/10.1371/journa....
Share
RELATED ARTICLE
| eISSN: | 1898-2263 |
| ISSN: | 1232-1966 |
Improvement of visual identification of the journal - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher Education allocated to the activities of disseminating science.
Generation of the DOI (Digital Object Identifier) - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher
© 2006-2024 Journal hosting platform by Bentus
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
